Abbvie Inc v. Aurobindo Pharma U.S.A., Inc
Abbvie Inc v. Aurobindo Pharma U.S.A., Inc is a federal patent - anda lawsuit filed on 03/29/2024 in the District Court, D. New Jersey. The case is currently open in the federal court system.
- Court
- District Court, D. New Jersey (D.N.J.)
Official Court Website → - Assigned judge
- Zahid N. Quraishi · 418 cases in index
- Docket number
- 3:24-cv-04403
- Cause
- 15:1126 Patent Infringement
15 U.S.C. § 1126 - Nature of suit
- 835 Patent - Abbreviated New Drug Application(ANDA)
Hatch-Waxman patent disputes over a generic-drug (ANDA) application. - Jurisdiction
- Federal Question
- Jury demand
- None
- Date filed
- 03/29/2024
623 Patent - ANDA cases in this court are indexed here.
Parties
- plaintiff · AbbVie Inc Pharmaceuticals & Biotechnology · 5032 cases
- defendant · Aurobindo Pharma U.S.A., Inc · 4 cases
Part of a Larger Litigation Pattern
This is one of 5 Patent - ANDA cases in our index naming AUROBINDO PHARMA U.S.A., INC — a possible mass-tort or coordinated-litigation cluster.
About Patent - ANDA Lawsuits
ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.
Frequently Asked Questions
What is Abbvie Inc v. Aurobindo Pharma U.S.A., Inc?
Abbvie Inc v. Aurobindo Pharma U.S.A., Inc is a federal patent - anda lawsuit filed on 03/29/2024 in the District Court, D. New Jersey. The case is currently open in the federal court system. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.
What type of case is this?
It is classified as “Patent - ANDA” under the federal nature-of-suit system. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.
What court is the case in?
The case is in the District Court, D. New Jersey, docket number 3:24-cv-04403.
When was the case filed?
Abbvie Inc v. Aurobindo Pharma U.S.A., Inc was filed on 03/29/2024. The case is currently open.
What law is the case brought under?
The docket lists the cause as 15 U.S.C. § 1126.
Other Cases Involving These Parties
Related Patent - ANDA Cases
Source: public U.S. federal court record (docket 68393885).